Berry Genomics Co (000710.SZ) Akcie Kurz

Berry Genomics Co., Ltd. engages in the gene detection and sales of equipment and reagents of high-throughput sequencing technology. The company is headquartered in Beijing, Beijing and currently employs 1,438 full-time employees. The firm's business is comprised of basic scientific research services, medical testing services, testing reagent sales and testing equipment sales. The basic scientific research services business provides the clients with multiple sequencing platforms for testing projects, such as transcriptome sequencing, human whole exome sequencing and whole genome sequencing. The medical testing services business include tumor genetic testing services, genetic disease genetic testing services and reproductive health testing services. The firm sells a range of reagents and equipment, including NextSeq CN500 gene sequencer and general reagents for sequencing reactions.